Rainbow Children’s Medicare share price surged over 2% on the back of strong financial results for Q2 FY25. The company reported solid growth in both sales and profit, showcasing its resilience in the healthcare sector.
For the quarter ended September 2024, Rainbow Children’s Medicare posted a 25.37% increase in net profit, reaching ₹78.87 crore compared to ₹62.91 crore in the same quarter last year. Sales also rose by 25.48%, with revenue at ₹417.46 crore, up from ₹332.68 crore in Q2 FY24.
Key financial highlights (Q2 FY25 vs Q2 FY24):
- Sales: ₹417.46 crore, up 25.48%
- Operating Profit Margin (OPM): 35.23% (compared to 35.34% last year)
- Profit Before Tax (PBT): ₹105.35 crore, up 24%
- Net Profit (NP): ₹78.87 crore, up 25.37%
- EBITDA: Increased 25.8% year-on-year (YoY)
As of 9:42 am, the shares were trading 2.06% higher at ₹1,450.00
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
